Thomas Kozel

Thomas Kozel cofounded DxDiscovery in 2012; he currently serves as the company’s Vice-President. Dr. Kozel is also a Professor of Microbiology at the University of Nevada School of Medicine. Dr. Kozel has 45 years of experience in study of the molecular immunology, microbial pathogenesis and host responses to fungal and bacterial pathogens. Interests include immunochemistry and monoclonal antibody technologies and the identification of targets for immunodiagnosis and immunotherapy of infectious disease. These interests are core technologies of DxDiscovery. He has secured greater than $25 million in NIH grant funding, published more than 135 scientific papers, is an NIH MERIT awardee, and served on more than 25 NIH scientific review panels. Dr. Kozel received his B.A., M.S. and Ph.D. degrees in microbiology from the University of Iowa. He has been a visiting scholar at the Rockefeller University and Oxford University.